Aziyo Biologics's total assets for Q4 2024 were $36.13M, a decrease of -25.37% from the previous quarter. ELUT total liabilities were $82.39M for the fiscal quarter, a -7.06% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.